While this inhibitory effect in organoids likely targeted tumor growth rather than metastasis directly, consistent with previous studies 12, it suggests the translational potential of CPS1 inhibitors for lung cancer patients presenting with early signs of metastasis. The gene discussed is CPS1; the disease is neoplasm.